Publication | Closed Access
The Addition of Bevacizumab to FOLFOX4 Prolongs Survival in Relapsed Colorectal Cancer: Interim Data from the ECOG 3200 Trial
20
Citations
4
References
2005
Year
Gastrointestinal OncologyMedicineColorectal CancerPathologyRelapsed Colorectal CancerCancer TreatmentOncologyRadiation OncologyEcog 3200Cancer ResearchInterim Data
| Year | Citations | |
|---|---|---|
Page 1
Page 1